NOTCH3 and neoplasm: Preclinical studies primarily evaluate short-term (4–8 weeks) anti-tumor effects, but long-term administration may disrupt Notch-dependent normal physiological processes-such as ursolic acid’s potential to inhibit Notch3 in hepatic stellate cells (Zhang, 2023), which could interfere with liver tissue repair if used chronically.